A review of glioblastoma 3D cell culture models: Properties and applications in drug screening

Glioblastoma is classified as the most aggressive brain tumor due to its invasive nature and rapid progression. It is clinically treated using combinations of different chemotherapeutic agents, such as Temozolomide, Carmustine, and Lomustine, along with surgery and/or radiotherapy. GBM cells often develop resistance to traditional treatments, leading to a need for the development of new therapies. But due to the complexity of the tumor microenvironment and its limited representation in laboratory models, most newly developed drugs fail to pass clinical trials, highlighting the need for clinically relevant preclinical testing models. Clinically relevant models would incorporate GBM cells in a three-dimensional setting that mimics the in vivo cancer environment and include key features such as the tumor microenvironment and the blood-brain barrier. This narrative review aims to identify 3D cell culture protocols that incorporate the tumor into such an environment and to assess their potential as models for testing glioblastoma treatments. A comprehensive search on Google Scholar and PubMed using the keywords Glioblastoma organoids”, “Brain Organoids”, “Glioblastoma 3D cell culture”, “Brain 3D cell culture”, and “Advances in brain cell culture” was done to identify published research work. The PRISMA 2020 guidelines were used to select the papers. The inclusion of the scientific research articles into the study was based on the presence or absence of brain tumor organoids/spheroids and/or cerebral organoids. After shortlisting, 28 studies were analyzed for the review, and the extracted data were put in a Table. The co-culture of cerebral organoids with GBM cells or Glioblastoma stem cells (GSCs)-based spheroids was the most common protocol used in the studies (38%). 14.3% of the studies reported the in vitro establishment of the BBB, and 50% of these studies used bioprinting and microfluidics-based approaches. 68% of the total studies included patient-derived samples, and preservation of patient-specific heterogeneity in the 3D models was also reported. This literature review provides a detailed analysis and summary of the different 3D cell culture techniques that have been developed to study the in vitro effects of the TME and BBB on drug treatment. The findings of this review will help researchers gain a comprehensive understanding of the different types of 3D brain cell culture models, including their design, biological relevance, and translational potential. By critically evaluating current methodologies, applications, and limitations, this review provides a consolidated framework to guide model selection for neuroscience research, disease modelling, and drug screening. Furthermore, the insights presented may support the advancement of more physiologically relevant in vitro brain models and inform future research directions toward improved reproducibility and clinical translation.

Authors

Institutions

Publication Details

Journal
Biochemistry and Biophysics Reports
Published
2026-11-16
DOI
https://doi.org/10.1016/j.bbrep.2026.102841
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A review of glioblastoma 3D cell culture models: Properties and applications in drug screening

Bilal Javed, Furong Tian, Malik Hamza Sajjad
1 links
Biochemistry and Biophysics Reports
Glioma Diagnosis and Treatment
article

A review of glioblastoma 3D cell culture models: Properties and applications in drug screening

Bilal Javed, Furong Tian, Malik Hamza Sajjad
article en

Abstract

Glioblastoma is classified as the most aggressive brain tumor due to its invasive nature and rapid progression. It is clinically treated using combinations of different chemotherapeutic agents, such as Temozolomide, Carmustine, and Lomustine, along with surgery and/or radiotherapy. GBM cells often develop resistance to traditional treatments, leading to a need for the development of new therapies. But due to the complexity of the tumor microenvironment and its limited representation in laboratory models, most newly developed drugs fail to pass clinical trials, highlighting the need for clinically relevant preclinical testing models. Clinically relevant models would incorporate GBM cells in a three-dimensional setting that mimics the in vivo cancer environment and include key features such as the tumor microenvironment and the blood-brain barrier. This narrative review aims to identify 3D cell culture protocols that incorporate the tumor into such an environment and to assess their potential as models for testing glioblastoma treatments. A comprehensive search on Google Scholar and PubMed using the keywords Glioblastoma organoids”, “Brain Organoids”, “Glioblastoma 3D cell culture”, “Brain 3D cell culture”, and “Advances in brain cell culture” was done to identify published research work. The PRISMA 2020 guidelines were used to select the papers. The inclusion of the scientific research articles into the study was based on the presence or absence of brain tumor organoids/spheroids and/or cerebral organoids. After shortlisting, 28 studies were analyzed for the review, and the extracted data were put in a Table. The co-culture of cerebral organoids with GBM cells or Glioblastoma stem cells (GSCs)-based spheroids was the most common protocol used in the studies (38%). 14.3% of the studies reported the in vitro establishment of the BBB, and 50% of these studies used bioprinting and microfluidics-based approaches. 68% of the total studies included patient-derived samples, and preservation of patient-specific heterogeneity in the 3D models was also reported. This literature review provides a detailed analysis and summary of the different 3D cell culture techniques that have been developed to study the in vitro effects of the TME and BBB on drug treatment. The findings of this review will help researchers gain a comprehensive understanding of the different types of 3D brain cell culture models, including their design, biological relevance, and translational potential. By critically evaluating current methodologies, applications, and limitations, this review provides a consolidated framework to guide model selection for neuroscience research, disease modelling, and drug screening. Furthermore, the insights presented may support the advancement of more physiologically relevant in vitro brain models and inform future research directions toward improved reproducibility and clinical translation.

Biochemistry and Biophysics ReportsVol. 48
Technological University Dublin (IE)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon